研究单位：[1]Xuanwu Hospital, Beijing[2]Henan Provincial People's Hospital[3]The First Affiliated Hospital of Zhengzhou University[4]First Affiliated Hospital of Xinjiang Medical University[5]Beijing Tiantan Hospital[6]Qilu Hospital of Shandong University[7]Nanfang Hospital, Southern Medical University[8]Second Affiliated Hospital of Nanchang University[9]The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School[10]Wuhan Union Hospital, China
Since its launch in China in 2014, Pipeline Embolization Device (PED) has been widely used in the treatment of intracranial aneurysms. It is necessary to collect data on the long-term safety and efficacy of the Pipeline Embolization Device (PED) in the treatment of intracranial aneurysms, analyze its long-term effectiveness, and provide guidance for clinical practice.
